Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c)

Area of Science:

• Cardiovascular Medicine
• Hematology
• Endocrinology

Background:

• Type 2 diabetes is associated with impaired platelet function, but the link to long-term glycemic control is unclear.
• Glycosylated hemoglobin (HbA1c) is a key indicator of long-term glycemic control in diabetes.

Purpose of the Study:

• To investigate the relationship between HbA1c levels and platelet reactivity in older adults with type 2 diabetes.
• To compare platelet mitochondrial injury and other activation markers in relation to HbA1c.

Main Methods:

• Compared platelet reactivity in vitro in type 2 diabetes patients with low vs. high HbA1c.
• Used flow cytometry to assess mitochondrial transmembrane potentials, fibrinogen receptor activity, lysosomal exocytosis, and platelet procoagulant characteristics after agonist stimulation (thrombin and collagen).

Main Results:

• Platelet mitochondrial injury was significantly higher in the high HbA1c group compared to the low HbA1c group after in vitro agonist stimulation.
• HbA1c levels did not influence fibrinogen receptor activity, lysosomal secretion, or the generation of procoagulant platelets.

Conclusions:

• Elevated long-term glycemic control (high HbA1c) in type 2 diabetes is associated with increased platelet mitochondrial damage.
• Specific platelet functions, beyond mitochondrial integrity, appear independent of HbA1c levels in this population.